Fund Holdings — VR Adviser, LLC

Total Portfolio Value:
$1.91B
Total Bought:
$190.03M
Total Sold:
$68.82M
Net Transaction:
+$121.21M
Notable People:
Evan Wolfe Neu, Jessica Tong Baron
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Apogee Therapeutics Inc8,493,3218,493,3210$334.21M$498.90M26.13%+$164.69M
Ocular Therapeutix, Inc.(OCUL)12,762,46212,762,4620$87.30M$111.03M5.82%+$23.74M
Enliven Therapeutics Inc4,026,3314,026,3310$94.10M$102.83M5.39%+$8.74M
Viridian Therapeutics, Inc.(VRDN)3,882,6713,882,709+38$50.51M$88.33M4.63%+$37.82M
Applied Therapeutics Inc9,542,8719,825,000+282,129$44.57M$83.51M4.37%+$38.95M
Spyre Therapeutics, Inc.(SYRE)2,685,4482,685,4480$63.13M$78.98M4.14%+$15.84M
Dyne Therapeutics, Inc.(DYN)2,173,9132,173,9130$76.72M$78.09M4.09%+$1.37M
Oruka Therapeutics, Inc.(ORKA)03,085,620+3,085,620$0$75.63M3.96%+$75.63M
Kalvista Pharmaceuticals Inc6,249,7316,249,7310$73.62M$72.37M3.79%-$1.25M
Pharvaris N V
COM
3,395,6063,395,6060$63.84M$62.89M3.29%-$950.8K
Cogent Biosciences, Inc.(COGT)5,684,1675,684,1670$47.92M$61.39M3.22%+$13.47M
Dianthus Therapeutics, Inc.(DNTH)2,094,3731,744,373-350,000$54.20M$47.76M2.50%-$6.44M
4d Molecular Therapeutics In4,400,0004,400,0000$92.36M$47.56M2.49%-$44.79M
Merus N V1,263,214907,963-355,251$74.74M$45.36M2.38%-$29.38M
ORIC Pharmaceuticals, Inc.(ORIC)4,394,5274,394,5270$31.07M$45.04M2.36%+$13.97M
Erasca, Inc.(ERAS)16,216,21616,216,2160$38.27M$44.27M2.32%+$6.00M
Praxis Precision Medicines, Inc.(PRAX)706,131706,1310$29.21M$40.63M2.13%+$11.43M
Astria Therapeutics Inc3,608,6453,458,645-150,000$32.84M$38.08M1.99%+$5.24M
Terns Pharmaceuticals Inc3,410,0583,410,0580$23.22M$28.44M1.49%+$5.22M
Aquestive Therapeutics Inc5,555,5555,555,5550$14.44M$27.67M1.45%+$13.22M
Edgewise Therapeutics, Inc.(EWTX)1,818,1821,000,000-818,182$32.75M$26.69M1.40%-$6.06M
Artiva Biotherapeutics, Inc.(ARTV)01,609,569+1,609,569$0$24.87M1.30%+$24.87M
Engene Holdings Inc
COM
2,825,9833,565,841+739,858$26.65M$23.53M1.23%-$3.11M
Cullinan Therapeutics, Inc.(CGEM)1,379,9651,379,9650$24.07M$23.10M1.21%-$966.0K
Mersana Therapeutics Inc11,328,00011,328,0000$22.77M$21.41M1.12%-$1.36M
Taysha Gene Therapies, Inc.(TSHA)9,000,0009,000,0000$20.16M$18.09M0.95%-$2.07M
ABIVAX Société AnonymeADS(ABVX)1,345,7801,345,7800$17.79M$15.50M0.81%-$2.29M
Trevi Therapeutics, Inc.(TRVI)3,422,6373,422,656+19$10.20M$11.43M0.60%+$1.23M
Arvinas, Inc.(ARVN)627,788454,450-173,338$16.71M$11.19M0.59%-$5.52M
Adverum Biotechnologies Inc1,467,0481,467,0480$10.06M$10.30M0.54%+$234.7K
Century Therapeutics, Inc.(IPSC)5,389,2595,389,2590$13.74M$9.22M0.48%-$4.53M
Zura Bio LimitedCL A(ZURA)6,023,1662,023,166-4,000,000$21.08M$8.21M0.43%-$12.87M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
750,000750,0000$7.54M$7.51M0.39%-$30.0K
Cabaletta Bio, Inc.(CABA)1,563,9521,563,9520$11.70M$7.38M0.39%-$4.32M
CASI Pharmaceuticals, Inc.(CASIF)111,686987,259+875,573$614.3K$6.08M0.32%+$5.47M
Tenaya Therapeutics, Inc.(TNYA)1,555,5561,555,5560$4.82M$3.00M0.16%-$1.82M
Instil Bio, Inc.(TIL)033,177+33,177$0$2.23M0.12%+$2.23M
Tenax Therapeutics, Inc.(TENX)0208,333+208,333$0$720.8K0.04%+$720.8K
Arca Biopharma Inc866,3750-866,375$3.32M$0—-$3.32M
Page 1 of 1
VR Adviser, LLC — 13F Holdings — Q3 2024 | TickerTrail